|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print June 4, 2007 J. Lipid Res., doi:10.1194/jlr.M700188-JLR200
Biochemistry, Cell Biology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601
Corresponding Author: syokoyam{at}med.nagoya-cu.ac.jp
Fibroblast growth factor-1 (FGF-1) is synthesized and secreted by astrocytes and stimulates biogenesis of apolipoprotein (apo) E-high density lipoprotein (HDL) by an autocrine mechanism in astrocytes (Biochim. Biophys. Acta 1589, 261-272, 2002 and J. Lipid Res. 46, 679-686, 2005). This reaction plays a crucial role in the recovery mechanism of brain injury (Neurochem. Int. 45, 23-30, 2004). We investigated mechanism for FGF-1 to stimulate apoE-HDL biogenesis in astrocytes focusing on signaling pathways. FGF-1 stimulated cholesterol biosynthesis without enhancing its release in apoE-deficient mouse astrocytes, indicating a signaling pathway independent of apoE biosynthesis up-regulation. SU5402, an inhibitor of the FGF-1 receptor, inhibited the FGF-1-induced phosphorylation of MEK, ERK, and Akt, as well as stimulation of all the apoE-HDL biogenesis-related events in rat astrocytes. LY294002, an inhibitor of phosphatidylinositide 3-OH kinase (PI3K) and therefore of Akt phosphorylation, inhibited secretion of apoE-HDL but did not influence cholesterol biosynthesis, while U0126, an inhibitor of MEK and consequently of ERK phosphorylation, inhibited cholesterol biosynthesis but not apoE-HDL secretion. Increase of apoE-mRNA by FGF-1 was uninfluenced by either inhibitor. When rat apoE/pcDNA3.his was transfected to the transformed rat astrocyte cells GA-1 that otherwise do not synthesize apoE (GA-1/25), apoE-mRNA level was not influenced but its secretion was increased by FGF-1 as phosphorylation of Akt was induced. This increase by FGF-1 was suppressed by LY294002. Lipid biosynthesis was also increased by FGF-1 in GA-1/25 and suppressed by U0126. We thus concluded that FGF-1 upregulates apoE-HDL biogenesis by using at least three independent signaling pathways. The PI3K/Akt pathway upregulates secretion of apoE/apoE-HDL, the MEK/ERK pathway stimulates cholesterol and other lipid biosynthesis, and an unknown pathway enhances apoE transcription.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||